FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Device Discontinuance Notification Guides

Federal Register notice: FDA makes available a final guidance entitled Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of...

latest-news-card-1
Federal Register

Panel to Discuss 506J Device List

Federal Register notice: FDA announces a 2/6/2024 advisory committee meeting on medical device supply chain resiliency and shortage issues.

latest-news-card-1
Federal Register

Final Guide on Device Computational Modeling

Federal Register notice: FDA makes available a final guidance entitled Assessing the Credibility of Computational Modeling and Simulation (CM&S) in Me...

latest-news-card-1
Human Drugs

FDA OKs AstraZeneca Breast Cancer Drug

FDA approves an AstraZeneca NDA for Truqap (capivasertib) for use with fulvestrant in certain adult patients with hormone receptor-positive, human epi...

latest-news-card-1
Human Drugs

Mercks Keytruda Gains OK in Gastric Cancer

FDA approves a Merck NDA for Keytruda (pembrolizumab) and its use with fluoropyrimidine- and platinum-containing chemotherapy for treating certain adu...

latest-news-card-1
Medical Devices

Asensus Surgical Recalls Robot Devices

Asensus Surgical recalls its Senhance Surgical System due to malfunctions that cause unintended movement of the robotically assisted surgical device.

Medical Devices

Braun Medical Infusion Pump Recall

Braun Medical recalls its Infusomat Space Volumetric Infusion Pump System due to faulty occlusion alarms.

Human Drugs

FDA Approves Expanded Xtandi Use

FDA approves Astellas Pharmas Xtandi (enzalutamide) for an expanded use treating non-metastatic castration-sensitive prostate cancer with biochemical...

latest-news-card-1
Human Drugs

BMS Gains Approval for Lung Cancer NDA

FDA approves a Bristol Myers Squibb NDA for Augtyro (repotrectinib) for treating adult patients with locally advanced or metastatic ROS1-positive non-...

latest-news-card-1
Federal Register

Regulatory Review Determination on Rozlytrek Corrected

Federal Register notice: FDA corrects a notice that appeared in the 7/8/2022 Federal Register that announced an agency determination of the regulatory...